Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

CPMP approves unified labeling for Intron A

Jan. 17, 1997

Immunotherapeutic vaccine for CML reported in patent literature

Jan. 17, 1997

Roche/Genentech marketing agreement for Roferon-A

Jan. 15, 1997

Aronex out-licenses antibody-toxin complex

Jan. 15, 1997

Treatment begun in pivotal trial of Coulter radioimmunopharmaceutical

Dec. 24, 1996

Positive clinical results reported for MDX-22 in AML patients

Dec. 12, 1996

Positive IDEC-C2B8 phase III trial results announced

Dec. 11, 1996

Medarex bispecific antibody enters phase II in colon cancer patients

Dec. 9, 1996

Sandoz claims MAbs against Lewis group antigens for therapeutic use

Nov. 25, 1996

IDEC to present final pivotal data on IDEC-C2B8

Nov. 22, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 8, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 8, 2024.
Sales balloon for GLP-1 drugs from Novo Nordisk, Eli Lilly
BioWorld
Nearly $3.8 billion was earned by Novo Nordisk A/S and Eli Lilly and Co. in the third quarter for their glucagon-like peptide-1 (GLP-1) drugs to treat obesity....
Regulatory actions for Oct. 31, 2024
BioWorld
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Capsida, Electra,...
Australia reimburses Vazkepa a decade after US approval
BioWorld
For the first time, Australians have access to CSL Inc.’s Vazkepa (icosapent ethyl/Vascepa) for managing cardiovascular disease more than a decade after the drug...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.